BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28928865)

  • 21. Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
    Shi S; Hua J; Liang C; Meng Q; Liang D; Xu J; Ni Q; Yu X
    Ann Surg; 2019 May; 269(5):944-950. PubMed ID: 29334560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8
    Mo R; Chen C; Pan L; Yu A; Wang D; Wang T
    J Thorac Dis; 2018 Sep; 10(9):5192-5198. PubMed ID: 30416766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the external validity of the AJCC 8
    Oweira H; Abdel-Rahman O; Mehrabi A; Reissfelder C
    J Gastrointest Oncol; 2019 Jun; 10(3):421-428. PubMed ID: 31183191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Eighth Edition of the American Joint Committee on Cancer TNM Staging System for Gastric Cancer: An Analysis of 7371 Patients in the SEER Database.
    Cao LL; Lu J; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Tu RH; Zheng CH; Huang CM
    Gastroenterol Res Pract; 2019; 2019():6294382. PubMed ID: 31097961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and prognostic factors of patients with stage IB and IIA pancreatic cancer according to the 8
    Li Y; Tang CG; Zhao Y; Cao WY; Qu GF
    World J Gastroenterol; 2017 Apr; 23(15):2757-2762. PubMed ID: 28487613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.
    Liu C; Cheng H; Jin K; Guo M; Lu Y; Wang Z; Yang C; Long J; Ni Q; Yu X; Luo G
    Pancreas; 2018 Jul; 47(6):742-747. PubMed ID: 29851752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the 7(th) edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort.
    Huang Y; Guo W; Shi S; He J
    J Thorac Dis; 2016 Jul; 8(7):1672-80. PubMed ID: 27499956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
    Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
    Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposal for a New TNM Stage based on the 7
    Qiu MZ; Wang ZX; Zhou YX; Yang DJ; Wang FH; Xu RH
    J Cancer; 2018; 9(19):3570-3576. PubMed ID: 30310514
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer.
    Shi J; Lian CL; Chi F; Zhou P; Lei J; Hua L; Wang J; He ZY; Wu SG
    Front Oncol; 2020; 10():570175. PubMed ID: 33392071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
    Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
    Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC-TNM staging.
    Liu L; Xu HX; He M; Wang W; Wang WQ; Wu CT; Wei RQ; Liang Y; Gao HL; Liu C; Xu J; Long J; Ni QX; Shao CH; Wang J; Yu XJ
    Surgery; 2018 Jun; 163(6):1280-1294. PubMed ID: 29548773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
    Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
    J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma.
    Park MY; Shin SH; Song KB; Hwang D; Lee JH; Lee YJ; Kim SC
    Ann Hepatobiliary Pancreat Surg; 2019 Feb; 23(1):46-55. PubMed ID: 30863807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.
    Pu N; Gao S; Xu Y; Zhao G; Lv Y; Nuerxiati A; Li JA; Wang D; Xu X; Kuang T; Wang X; Lou W; Liu L; Wu W
    J Cancer; 2017; 8(16):3362-3370. PubMed ID: 29158809
    [No Abstract]   [Full Text] [Related]  

  • 40. Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study.
    Zhang Y; Xu G; Chen M; Wei Q; Zhou T; Chen Z; Shen M; Wang P
    Front Oncol; 2020; 10():1018. PubMed ID: 32766130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.